The FDA approved Biogen's Alzheimer's drug. The company now has years to confirm it works.
Bio Pharma Dive
JUNE 8, 2021
Two near identical clinical trials of Aduhelm yielded conflicting results, dividing experts and even FDA staff. A third, confirmatory study is required, but Biogen has until 2029 to finish it.
Let's personalize your content